Promising pancreatic cancer drug may unlock new class of treatments targeting cancer's master switch
By
The Economist
Pure flour-power. Hearty enough to carry you through lunch.
Summary
The article discusses a promising new drug that targets pancreatic tumors and may have revealed a "master switch" for cancer. The treatment could represent the first of an entirely new class of cancer therapies, potentially transforming how various cancers are treated by targeting a fundamental mechanism common across different cancer types.
Key quotes
· 2 pulledA promising drug could be the first of an entirely new class of treatments
Treating pancreatic tumours may have revealed cancer's master switch
You might also wanna read
New Drug Shows Promise in Penetrating Pancreatic Cancer's 'Fibrotic Fortress'
Pancreatic cancer has an extremely low survival rate (97% mortality within 5 years for metastatic cases) due to late detection and the forma
sciencealert.com·3d ago
Combination therapy with RAS inhibitors shows promise for pancreatic cancer regression and resistance prevention
This research article presents a study on a targeted combination therapy for pancreatic ductal adenocarcinoma (PDAC), one of the deadliest c
pnas.org·3d ago
Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds
An experimental pill called daraxonrasib has shown promise in helping patients with advanced pancreatic cancer live longer. The drug works b
bit.ly·12d ago
Daraxonrasib nearly doubles survival in advanced pancreatic cancer by targeting previously 'undruggable' mechanism
A new drug called daraxonrasib has shown promise in nearly doubling survival rates for patients with advanced pancreatic cancer. Pancreatic
theconversation.com·10d ago
Experimental Drug Daraxonrasib Shows First Major Survival Benefit for Pancreatic Cancer Patients
An experimental drug called daraxonrasib has become the first treatment to substantially extend the lives of pancreatic cancer patients in a
nytimes.com·5h ago
Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds
An experimental pill called daraxonrasib has shown promise in helping patients with advanced pancreatic cancer live longer. The drug blocks
bit.ly·12d ago